“Although this study evaluates a small subset of astronauts, it's significantly larger than any previously published study of its kind involving astronauts or Russian cosmonauts," study author Donna R. Roberts said.
As of now the Tomosynthesis Mammographic Imaging Screening Trial (TMIST) has enrolled 16,505 participants across a number of certified mammography clinics in the U.S., Canada and Argentina, with more sites and participants to come.
Canadian Nuclear Laboratories and TRIUMF, the country’s particle accelerator center, have successfully produced actinium-225—a rare isotope that can be used for novel cancer therapy treatments.
“Because BI-RADS 3 breast lesions have up to 2% likelihood of malignancy, it is imperative that optimal follow-up of BI-RADS 3 test results be addressed...," authors of the new study published in JACR wrote.
The researchers analyzed 39 consecutive patients with 44 pathologically confirmed cirrhotic nodules who first received a CEUS exam, followed by a traditional follow-up ultrasound every three or four months for their study.
“Machine learning is a low-cost and efficient tool that could help physicians arrive to a quicker decision as to how to approach an indeterminate nodule,” lead author of the study, John Eisenbrey, PhD, said.
A new startup—Hyperfine—and its visionary leader Jonathan Rothberg are creating a new, portable MRI machine they believe can revolutionize the way doctors think about the technology.
“This technology has incredible potential to improve care, whether it is by better training doctors to perform procedures or helping patients know what to expect when they arrive at the hospital,” Ziv Haskal, creator of the technology said.
Exposure to radioiodine can lead to DNA damage in thyroid cells and other tissue, but new research suggests current radiation protection principles may not be sufficiently monitoring radiation exposure to nuclear medicine professionals.
Facial recognition software paired patient photographs to their corresponding MRI scans 83% of the time, according to new research out of the Mayo Clinic.